Articles | Volume 6, issue 9
https://doi.org/10.5194/jbji-6-413-2021
© Author(s) 2021. This work is distributed under
the Creative Commons Attribution 4.0 License.Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study
Related authors
Related subject area
Subject: Bone substitutes | Topic: All topics
Cited articles
Blaha, J. D., Calhoun, J. H., Nelson, C. L., Henry, S. L., Seligson, D.,
Esterhai, J. L., Jr., Heppenstall, R. B., Mader, J., Evans, R. P., and Wilkins, J.: Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis, Clin. Orthop. Relat. Res., 295, 8–12, 1993.
Bortolin, M., De Vecchi, E., Romano, C. L., Toscano, M., Mattina, R., and
Drago, L.: Antibiofilm agents against MDR bacterial strains: is bioactive
glass BAG-S53P4 also effective?, J. Antimicrob. Chemother., 71, 123–127,
https://doi.org/10.1093/jac/dkv327, 2016.
Cierny III, G., Mader, J. T., and Penninck, J. J.: A clinical staging system for adult osteomyelitis, Clin. Orthop. Relat. Res., 414, 7–24, https://doi.org/10.1097/01.blo.0000088564.81746.62, 2003.
Coraca-Huber, D. C., Fille, M., Hausdorfer, J., Putzer, D., and Nogler, M.:
Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms
grown on titanium discs in vitro, J. Orthop. Res., 32, 175–177,
https://doi.org/10.1002/jor.22463, 2014.
Detsch, R., Stoor, P., Grunewald, A., Roether, J. A., Lindfors, N. C., and
Boccaccini, A. R.: Increase in VEGF secretion from human fibroblast cells by
bioactive glass S53P4 to stimulate angiogenesis in bone, J. Biomed. Mater. Res. A, 102, 4055–4061, https://doi.org/10.1002/jbm.a.35069, 2014.